Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CBUS Stock Forecast 2026-2027
$2.13
Current Price
$172.48M
Market Cap
Buy 2
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to CBUS Price Targets
+1,073.7%
To High Target of $25.00
+651.2%
To Median Target of $16.00
+40.8%
To Low Target of $3.00
CBUS Price Momentum
+42.0%
1 Week Change
+73.2%
1 Month Change
+38.3%
1 Year Change
+22.4%
Year-to-Date Change
-49.2%
From 52W High of $4.19
+95.4%
From 52W Low of $1.09
📊 TOP ANALYST CALLS
Did CBUS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if CBUS is one of their latest high-conviction picks.
Latest CBUS Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, CBUS has a bullish consensus with a median price target of $16.00 (ranging from $3.00 to $25.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $2.13, the median forecast implies a 651.2% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Laurence Alexander at Jefferies, suggesting a 40.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CBUS Analyst Ratings
2
Buy
1
Hold
0
Sell
CBUS Price Target Range
Low
$3.00
Average
$16.00
High
$25.00
Current: $2.13
Latest CBUS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CBUS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 25, 2026 | Jefferies | Laurence Alexander | Hold | Maintains | $3.00 |
| Dec 8, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 12, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Mar 21, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jan 22, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Nov 11, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Oct 22, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 24, 2024 | Alliance Global Partners | Buy | Maintains | $N/A | |
| Sep 19, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Aug 12, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Jul 29, 2024 | Alliance Global Partners | Buy | Initiates | $N/A | |
| Jul 19, 2024 | Canaccord Genuity | Austin Moeller | Buy | Assumes | $22.00 |
| May 10, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Mar 22, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Oct 9, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A |
Cibus Inc. (CBUS) Competitors
The following stocks are similar to CBUS based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cibus Inc. (CBUS) Financial Data
Cibus Inc. has a market capitalization of $172.48M with a P/E ratio of -0.8x. The company generates $4.29M in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is +62.6% quarter-over-quarter, while maintaining an operating margin of -721.0% and return on equity of -190.1%.
Valuation Metrics
Market Cap
$172.48M
Enterprise Value
$408.41M
P/E Ratio
-0.8x
PEG Ratio
0.0x
Price/Sales
40.2x
Growth & Margins
Revenue Growth (YoY)
+62.6%
Gross Margin
N/A
Operating Margin
-721.0%
Net Margin
0.0%
EPS Growth
+62.6%
Financial Health
Cash/Price Ratio
+18.6%
Current Ratio
2.4x
Debt/Equity
778.3x
ROE
-190.1%
ROA
-11.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cibus Inc. (CBUS) Business Model
About Cibus Inc.
What They Do
Develops sustainable agricultural solutions using gene-editing.
Business Model
Cibus Inc. operates by leveraging its proprietary Rapid Trait Development System (RTDS) to enhance plant traits, which improves crop yield and resilience. The company partners with seed companies and agricultural producers to commercialize non-GMO, improved crop varieties, generating revenue through these collaborations and the sale of its innovative agricultural technologies.
Additional Information
Headquartered in San Diego, Cibus is positioned within the bioscience sector and plays a significant role in addressing food security and agricultural efficiency. Its focus on sustainable practices aligns with global environmental strategies, making it a key player in the evolving landscape of food supply and security.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
118
CEO
Dr. Peter R. Beetham B.Sc., Ph.D.
Country
United States
IPO Year
2017
Website
www.cibus.comCibus Inc. (CBUS) Latest News & Analysis
Latest News
Quick Summary
New EU rules classify crops improved without foreign DNA as conventionally bred, validating Cibus's 25-year development approach.
Why It Matters
New EU rules favoring non-GMO crops boost Cibus's market position, potentially increasing demand for its products and positively impacting its stock value.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cibus, Inc. appointed Craig Wichner as CEO, replacing Interim CEO Peter Beetham, who remains President and COO. Both resigned from the Board as part of a succession plan.
Why It Matters
Leadership changes can impact company direction and strategy, influencing investor confidence and stock performance. New CEO appointments often signal potential shifts in operational focus or priorities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Cibus Q1 Earnings Call Highlights
1 month ago
Quick Summary
Cibus (NASDAQ: CBUS) reported Q1 2026 results, advancing commercialization of its rice and sustainable ingredients, while reducing expenses and extending its cash runway to late Q1 2027.
Why It Matters
Cibus's Q1 2026 results indicate progress in commercialization and expense management, enhancing its financial stability and extending its cash runway, which boosts investor confidence.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Cibus, Inc. (CBUS) held its Q1 2026 earnings call, providing updates on financial performance and future outlook. Further details can be referenced in the full transcript.
Why It Matters
Cibus, Inc.'s Q1 2026 earnings call provides insights into financial performance, operational strategies, and future outlook, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Cibus, Inc. (Nasdaq: CBUS) reported its Q1 2026 financial results on May 14, 2026, and will host a conference call at 4:30 p.m. for further business updates.
Why It Matters
Cibus, Inc.'s quarterly financial results and business update can influence stock performance and investor sentiment, indicating growth potential or challenges in the agricultural tech sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cibus (CBUS) reported a quarterly loss of $0.33 per share, better than the expected loss of $0.35, and an improvement from a loss of $0.74 per share a year prior.
Why It Matters
Cibus's smaller-than-expected loss signals improved performance and potential recovery, which may boost investor confidence and affect stock valuation positively.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About CBUS Stock
What is Cibus Inc.'s (CBUS) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, Cibus Inc. (CBUS) has a median price target of $16.00. The highest price target is $25.00 and the lowest is $3.00.
Is CBUS stock a good investment in 2027?
According to current analyst ratings, CBUS has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.13. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CBUS stock?
Wall Street analysts predict CBUS stock could reach $16.00 in the next 12 months. This represents a 651.2% increase from the current price of $2.13. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cibus Inc.'s business model?
Cibus Inc. operates by leveraging its proprietary Rapid Trait Development System (RTDS) to enhance plant traits, which improves crop yield and resilience. The company partners with seed companies and agricultural producers to commercialize non-GMO, improved crop varieties, generating revenue through these collaborations and the sale of its innovative agricultural technologies.
What is the highest forecasted price for CBUS Cibus Inc.?
The highest price target for CBUS is $25.00 from at , which represents a 1,073.7% increase from the current price of $2.13.
What is the lowest forecasted price for CBUS Cibus Inc.?
The lowest price target for CBUS is $3.00 from Laurence Alexander at Jefferies, which represents a 40.8% increase from the current price of $2.13.
What is the overall CBUS consensus from analysts for Cibus Inc.?
The overall analyst consensus for CBUS is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $16.00.
How accurate are CBUS stock price projections?
Stock price projections, including those for Cibus Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2026 6:33 AM UTC